Advertisement

Ads Placeholder
Loading...

Ligand Pharmaceuticals Incorporated

LGNYZ•PNK
Healthcare
Medical - Pharmaceuticals
$0.04
$-0.01(-17.78%)
U.S. Market opens in 49h 13m

Ligand Pharmaceuticals Incorporated (LGNYZ) Stock Overview

Explore Ligand Pharmaceuticals Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap737.8K
P/E Ratio0.01
EPS (TTM)N/A
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$0.06
1 Year Target$0.03

LGNYZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ligand Pharmaceuticals Incorporated (LGNYZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.01 and a market capitalization of 737.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-38.33%
6-Month Change
47.41%
Year-to-Date (YTD) Change
N/A
1-Year Change
164.29%
3-Year Change
1021.21%
5-Year Change
164.29%
All-Time (Max) Change
-63.00%

Contact Information

https://www.ligand.com
858 550 7500
555 Heritage Drive, Jupiter, FL, 33458

Company Facts

680 Employees
CountryUS

Frequently Asked Questions